疾病标签「多囊卵巢综合征」对年轻女性接受超声检查意愿及心理社会结局的影响:一项随机在线研究
该实验性在线研究将181名年轻女性随机分配至2(多囊卵巢综合征疾病标签 vs 无疾病标签)×2(超声检查不可靠性信息 vs 无信息)设计的四种假设医生就诊场景。结果显示,接受多囊卵巢综合征标签者接受超声检查的意愿更高、感知病情更严重且自尊更低;在获得过度诊断信息后,无论分组如何,检查意愿和感知严重程度均下降。
要点
- 接受多囊卵巢综合征标签者接受超声检查意愿显著更高(均值6.62 vs 5.76,P=0.033)。
- 接受多囊卵巢综合征标签者感知病情更严重(17.17 vs 15.82,P=0.019)且自尊更低(25.86 vs 27.56,P=0.031)。
- 获得过度诊断信息后,检查意愿和感知严重程度均下降(均P<0.001)。
核心结论
- 在假设场景中给予多囊卵巢综合征疾病标签可使参与者接受超声检查的意愿更高、感知病情更严重且自尊更低。
- 这些发现表明多囊卵巢综合征标签可能带来负面后果,在临床获益不确定时诊断更多女性前考虑标签影响至关重要。
研究设计与样本
- 实验性在线研究,将181名年轻女性随机分配至2(多囊卵巢综合征疾病标签 vs 无疾病标签)×2(超声检查不可靠性信息 vs 无信息)设计的四种假设医生就诊场景。
- 参与者为大学生(平均年龄19.4岁)。
主要发现
- 接受多囊卵巢综合征标签者接受超声检查意愿显著更高(均值6.62 vs 5.76,P=0.033,差值95%CI=0.069-1.599)。
- 接受多囊卵巢综合征标签者感知病情更严重(17.17 vs 15.82,P=0.019,差值95%CI=0.229-2.479)。
- 接受多囊卵巢综合征标签者自尊更低(25.86 vs 27.56,P=0.031,差值95%CI=-3.187至-0.157)。
- 获得过度诊断信息后,检查意愿和感知严重程度均下降,无论分组如何(均P<0.001)。
局限性
- 本研究使用假设场景,面临真实多囊卵巢综合征诊断的女性结局可能比本研究受影响更大。
- 假设设计使多囊卵巢综合征的症状和风险在各组间保持恒定,对检查意愿和心理社会结局的影响可直接归因于疾病标签效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does the disease label 'polycystic ovary syndrome' (PCOS) have an impact on desire for medical testing and psychosocial outcomes? SUMMARY ANSWER: When given the disease label PCOS in a hypothetical scenario, participants had higher intention to have an ultrasound, perceived the condition to be more severe and had lower self-esteem than those not given the disease label. WHAT IS KNOWN ALREADY: Widening diagnostic criteria and improved imaging sensitivity have increased the number of reproductive-aged women diagnosed with PCOS from 4% to 8% to up to 21%. The uncertain clinical benefit of knowing this diagnosis needs to be weighed against the potential for poor psychological outcomes in women labelled with PCOS. STUDY DESIGN, SIZE, DURATION: This experimental online study randomised 181 young women to receive one of four hypothetical scenarios of a doctor's visit in a 2 (PCOS disease label versus no disease label) x 2 (information about unreliability of ultrasounds in clarifying diagnosis versus no information) design. PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were university students (mean age: 19.4). After presenting the scenario, intention to have an ultrasound, negative affect, self-esteem, perceived severity of condition, credibility of the doctor and interest in a second opinion were measured. Participants were then presented with a second scenario, where the possibility of PCOS overdiagnosis was mentioned. Change in intention and perceived severity were then measured. MAIN RESULTS AND THE ROLE OF CHANCE: Participants given the PCOS label had significantly higher intention to have an ultrasound (mean = 6.62 versus mean = 5.76, P = 0.033, 95% CI(difference) = 0.069-1.599), perceived the condition to be more severe (17.17 versus 15.82, P = 0.019, 95% CI(difference) = 0.229-2.479) and had lower self-esteem (25.86 versus 27.56, P = 0.031, 95% CI(difference) = -3.187 to -0.157). After receiving overdiagnosis information, both intention and perceived severity decreased, regardless of condition (both P < 0.001). LIMITATIONS, REASONS FOR CAUTION: This study used hypothetical scenarios; it is likely that for women facing a real diagnosis of PCOS, outcomes would be more affected than in the current study. The hypothetical design, however, allowed the symptoms and risks of PCOS to be held constant across conditions, the impact on intention and psychosocial outcomes directly attributable to the effect of the disease label. WIDER IMPLICATIONS OF THE FINDINGS: These findings demonstrate the potential negative consequences of PCOS labelling. It is crucial we consider the impact of the label before diagnosing more women with PCOS when clinical benefit of this diagnosis is uncertain. STUDY FUNDING/COMPETING INTEREST(S): This paper was written with support from a NHMRC grant awarded to the Screening and Test Evaluation Program. J.J. is supported by an NHMRC Early Career Fellowship. K.M. is supported by an NHMRC Career Development Fellowship. The authors declare that no competing interests exist. TRIAL REGISTRATION NUMBER: ACTRN12617000111370. TRIAL REGISTRATION DATE: 20/01/2017. DATE OF FIRST PATIENT'S ENROLMENT: 01/06/2015.
引用
- Copp T, McCaffery K, Azizi L, et al. Influence of the disease label 'polycystic ovary syndrome' on intention to have an ultrasound and psychosocial outcomes: a randomised online study in young women. Hum Reprod. 2017. PMID: 28333180. doi:10.1093/humrep/dex029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。